These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16173088)

  • 1. Application of microscopy in authentication of Chinese patent medicine--Bo Ying compound.
    Zhao ZZ; Hu YN; Wong YW; Gigi Wong WC; Wu K; Jiang ZH; Kang T
    Microsc Res Tech; 2005 Aug; 67(6):305-11. PubMed ID: 16173088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Present situation and prospect of quality standardization of Chinese patent medicines].
    Gao XM; Zhang JJ; Zhang DQ; Wang JX; Ou LN; Chen SH
    Zhongguo Zhong Yao Za Zhi; 2007 May; 32(9):868-72. PubMed ID: 17639993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on quality evaluation of Chinese traditional patent medicine with chemical patterm recognition (I)].
    Su W; Feng Y; Wu Z; Zhang R; Ye W; Peng D
    Zhong Yao Cai; 1998 Jun; 21(6):311-4. PubMed ID: 12567528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Authentication of the 31 species of toxic and potent Chinese materia medica by microscopic technique assisted by ICP-MS analysis, part 4: four kinds of toxic and potent mineral arsenical CMMs.
    Li Q; Chu C; Wang YQ; Chen HB; Li P; Zhao ZZ
    Microsc Res Tech; 2011 Jan; 74(1):1-8. PubMed ID: 21181703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacognostical study on Fructus Hordei germinatus, Fructus Oryzae germinatus and Fructus Setariae germinatus].
    Wang GX; Liu HJ; Li P; Ye XL
    Zhong Yao Cai; 2009 Apr; 32(4):500-3. PubMed ID: 19645231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Authentication of the 31 species of toxic and potent Chinese Materia medica (T/PCMM) by microscopic technique, part 1: three kinds of toxic and potent animal CMM.
    Xia L; Bai LP; Yi L; Liu BB; Chu C; Liang ZT; Li P; Jiang ZH; Zhao ZZ
    Microsc Res Tech; 2007 Nov; 70(11):960-8. PubMed ID: 17661389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular quantification, a new strategy for quality control of Chinese patent medicine containing animal-derived crude drug: Qi She in Jinlong capsule as an example.
    Li C; Li F; Ye H; Xie X; Liang Y; Tian E; Chao Z
    J Pharm Biomed Anal; 2022 Jan; 207():114428. PubMed ID: 34710727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Authentication of traditional Chinese medicine using infrared spectroscopy: distinguishing between ginseng and its morphological fakes.
    Yap KY; Chan SY; Lim CS
    J Biomed Sci; 2007 Mar; 14(2):265-73. PubMed ID: 17109185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA based identification of medicinal materials in Chinese patent medicines.
    Chen R; Dong J; Cui X; Wang W; Yasmeen A; Deng Y; Zeng X; Tang Z
    Sci Rep; 2012; 2():958. PubMed ID: 23233877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on HPLC fingerprint of Gentiana macrophylla].
    Cao XY; Li YH; Wang ZZ
    Zhong Yao Cai; 2008 Apr; 31(4):498-501. PubMed ID: 18661818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of minor quality evaluation marker compounds for Chinese patent medicine products using a two-leveled metabolomics strategy.
    Xue Z; Xu L; Shang Z; Shi X; Ye M; Qiao X
    J Chromatogr A; 2021 Aug; 1652():462354. PubMed ID: 34214834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new method of identifying Chinese crude drugs by comparing the characteristic content patterns of their chemical constituents].
    Gu Z
    Zhongguo Zhong Yao Za Zhi; 1992 May; 17(5):263-5, 319. PubMed ID: 1418558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The microscopical and HPLC identification of several" Muxiang" raw materials].
    Zong YY; Yu MT; Che ZT; Shao PZ; Huang JL
    Zhong Yao Cai; 2008 Sep; 31(9):1318-22. PubMed ID: 19180949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Weight variation of Chinese patent medicine].
    Wang BQ
    Zhong Yao Tong Bao; 1988 May; 13(5):28-9, 62. PubMed ID: 3197207
    [No Abstract]   [Full Text] [Related]  

  • 15. Purity control of some Chinese crude herbal drugs marketed in Italy.
    Mazzanti G; Battinelli L; Daniele C; Costantini S; Ciaralli L; Evandri MG
    Food Chem Toxicol; 2008 Sep; 46(9):3043-7. PubMed ID: 18586067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Probe into innovation and development of pattern of quality control and evaluation for Chinese medicine].
    Xiao XH; Jin C; Zhao ZZ; Xiao PG; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2007 Jul; 32(14):1377-81. PubMed ID: 17966345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of DNA metabarcoding technology in identification of Chinese patent medicines].
    Gao YZ; Wei J; Liu ZW; Zhou J
    Zhongguo Zhong Yao Za Zhi; 2019 Jan; 44(2):261-264. PubMed ID: 30989942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative and quantitative analysis in quality control of traditional Chinese medicines.
    Liang XM; Jin Y; Wang YP; Jin GW; Fu Q; Xiao YS
    J Chromatogr A; 2009 Mar; 1216(11):2033-44. PubMed ID: 18656880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research on evaluation criteria over quality as core index of high grade Chinese patent medicine].
    Liu Y; Yu HC; Zhang J; Chen C; Cheng JT; Song ZH; Liu A
    Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4356-4360. PubMed ID: 30583641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of high-performance liquid chromatography-electrospray ionization time-of-flight mass spectrometry for analysis and quality control of Radix Astragali and its preparations.
    Qi LW; Li P; Ren MT; Yu QT; Wen XD; Wang YX
    J Chromatogr A; 2009 Mar; 1216(11):2087-97. PubMed ID: 18353340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.